Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GraniteShares 2x Long NVDA Daily ETF (NVDL) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance

GraniteShares 2x Long NVDA Daily ETFTrade
Relay Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

GraniteShares 2x Long NVDA Daily ETF vs Relay Therapeutics Inc. Common Stock — how do they compare? GraniteShares 2x Long NVDA Daily ETF trades at $37.14 (market cap $3.56B), while Relay Therapeutics Inc. Common Stock trades at $18.07 (market cap $3.82B). The key difference: GraniteShares 2x Long NVDA Daily ETF and Relay Therapeutics Inc. Common Stock are close in size by market cap, and GraniteShares 2x Long NVDA Daily ETF is more actively traded (9,740,643 versus 4,332,079). Which is the better fit depends on your goals — on Pluang, investors hold GraniteShares 2x Long NVDA Daily ETF for 15 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.

NVDLRLAY
Market Cap
$3.56B$3.82B
Volume
9,740,6434,332,079
Sector
Leveraged / InverseHealth
52-Week High
$43.02$20.75
52-Week Low
$21.76$6.03
Typical Hold Time
15 Days0 Days
Enterprise Value
—$2.93B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GraniteShares 2x Long NVDA Daily ETF

NVDL, the GraniteShares 2x Long NVDA Daily ETF, trades at $37.335, down 5.65% on the day. Technical indicators show a bullish overall signal with strong moving average support, though oscillators remain neutral. Recent news highlights Nvidia's continued AI leadership and earnings beats, driving leveraged ETF interest. The ETF aims to deliver 2x daily returns of Nvidia stock, with technical analysis showing support at $36 and resistance at $38-39 levels.

The outlook remains tied to Nvidia's AI dominance and earnings performance. Investment opportunity exists through leveraged exposure to Nvidia's growth trajectory, though risks include daily reset leverage decay and Nvidia's high valuation. Recent SpaceX earnings have reshuffled AI chip trades, creating volatility. The ETF's performance depends on Nvidia maintaining its AI market leadership and execution.

Relay Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NVDL
100% Buy0% Sell
Avg holding period · 15 Days
RLAY
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About GraniteShares 2x Long NVDA Daily ETF

NVDL is a leveraged ETF that seeks daily investment results corresponding to 200% (2x) of the daily performance of NVIDIA Corporation (NVDA) stock. It is designed as a tactical trading tool for investors with a strong bullish (long) view on NVDA. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from two times the performance of the NVDA stock.

Read more on NVDL →

About Relay Therapeutics Inc. Common Stock

Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.

Read more on RLAY →